Free Trial

Advanced Medical Solutions Group (AMS) Competitors

Advanced Medical Solutions Group logo
GBX 283 0.00 (0.00%)
As of 12:37 PM Eastern

AMS vs. NIOX, TSTL, EKF, SPEC, and CREO

Should you buy Advanced Medical Solutions Group stock or one of its competitors? Advanced Medical Solutions Group's main competitors and comparable companies include NIOX Group (NIOX), Tristel (TSTL), EKF Diagnostics (EKF), INSPECS Group (SPEC), and Creo Medical Group (CREO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Advanced Medical Solutions Group compare to NIOX Group?

Advanced Medical Solutions Group (LON:AMS) and NIOX Group (LON:NIOX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

In the previous week, NIOX Group had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for NIOX Group and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.80 beat NIOX Group's score of 0.76 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
NIOX Group Positive

Advanced Medical Solutions Group has a beta of 0.759, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

Advanced Medical Solutions Group pays an annual dividend of GBX 2.86 per share and has a dividend yield of 1.0%. NIOX Group pays an annual dividend of GBX 1.55 per share and has a dividend yield of 2.5%. Advanced Medical Solutions Group pays out 173.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

NIOX Group has lower revenue, but higher earnings than Advanced Medical Solutions Group. NIOX Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£233.63M2.64£11.22M£1.65171.82
NIOX Group£47.50M5.38£995.88M£1.6338.72

21.5% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 7.6% of NIOX Group shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by company insiders. Comparatively, 5.1% of NIOX Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Advanced Medical Solutions Group presently has a consensus target price of GBX 278.33, indicating a potential downside of 1.82%. NIOX Group has a consensus target price of GBX 86, indicating a potential upside of 36.27%. Given NIOX Group's stronger consensus rating and higher possible upside, analysts clearly believe NIOX Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
NIOX Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NIOX Group has a net margin of 14.74% compared to Advanced Medical Solutions Group's net margin of 1.58%. NIOX Group's return on equity of 10.01% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group1.58% 1.44% 2.35%
NIOX Group 14.74%10.01%3.95%

Summary

NIOX Group beats Advanced Medical Solutions Group on 12 of the 17 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Tristel?

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Tristel has a net margin of 15.62% compared to Advanced Medical Solutions Group's net margin of 1.58%. Tristel's return on equity of 23.05% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.62% 23.05% 9.89%
Advanced Medical Solutions Group 1.58%1.44%2.35%

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.6%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.86 per share and has a dividend yield of 1.0%. Tristel pays out 85.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 173.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 0.80 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Tristel Neutral
Advanced Medical Solutions Group Positive

Tristel has a beta of 0.352, indicating that its stock price is 65% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.759, indicating that its stock price is 24% less volatile than the broader market.

Advanced Medical Solutions Group has a consensus price target of GBX 278.33, indicating a potential downside of 1.82%. Given Advanced Medical Solutions Group's stronger consensus rating and higher probable upside, analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

22.4% of Tristel shares are held by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are held by institutional investors. 21.0% of Tristel shares are held by insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£51.12M3.76£6.54M£16.5724.14
Advanced Medical Solutions Group£233.63M2.64£11.22M£1.65171.82

Summary

Tristel beats Advanced Medical Solutions Group on 9 of the 17 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to EKF Diagnostics?

EKF Diagnostics (LON:EKF) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Advanced Medical Solutions Group has higher revenue and earnings than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EKF Diagnostics£51.35M2.01£4.68M£0.5841.57
Advanced Medical Solutions Group£233.63M2.64£11.22M£1.65171.82

EKF Diagnostics has a beta of 0.503, meaning that its share price is 50% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.759, meaning that its share price is 24% less volatile than the broader market.

EKF Diagnostics currently has a consensus target price of GBX 35, indicating a potential upside of 45.16%. Advanced Medical Solutions Group has a consensus target price of GBX 278.33, indicating a potential downside of 1.82%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, equities research analysts plainly believe EKF Diagnostics is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

EKF Diagnostics has a net margin of 4.86% compared to Advanced Medical Solutions Group's net margin of 1.58%. EKF Diagnostics' return on equity of 3.58% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
EKF Diagnostics4.86% 3.58% 5.27%
Advanced Medical Solutions Group 1.58%1.44%2.35%

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 0.80 beat EKF Diagnostics' score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
EKF Diagnostics Neutral
Advanced Medical Solutions Group Positive

21.5% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. 40.2% of EKF Diagnostics shares are owned by insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

EKF Diagnostics and Advanced Medical Solutions Group tied by winning 7 of the 14 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to INSPECS Group?

INSPECS Group (LON:SPEC) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

INSPECS Group has a beta of 1.603, meaning that its share price is 60% more volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.759, meaning that its share price is 24% less volatile than the broader market.

0.7% of INSPECS Group shares are owned by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. 19.6% of INSPECS Group shares are owned by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Advanced Medical Solutions Group has a consensus price target of GBX 278.33, indicating a potential downside of 1.82%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than INSPECS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Advanced Medical Solutions Group has a net margin of 1.58% compared to INSPECS Group's net margin of -0.52%. Advanced Medical Solutions Group's return on equity of 1.44% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-0.52% -1.19% 0.45%
Advanced Medical Solutions Group 1.58%1.44%2.35%

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 0.80 beat INSPECS Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
INSPECS Group Neutral
Advanced Medical Solutions Group Positive

Advanced Medical Solutions Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£193.23M0.49-£4.11M-£5.34N/A
Advanced Medical Solutions Group£233.63M2.64£11.22M£1.65171.82

Summary

Advanced Medical Solutions Group beats INSPECS Group on 13 of the 15 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Creo Medical Group presently has a consensus price target of GBX 40, suggesting a potential upside of 295.06%. Advanced Medical Solutions Group has a consensus price target of GBX 278.33, suggesting a potential downside of 1.82%. Given Creo Medical Group's higher possible upside, research analysts plainly believe Creo Medical Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Creo Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Advanced Medical Solutions Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creo Medical Group£7M6.50-£25.04M-£5.00N/A
Advanced Medical Solutions Group£233.63M2.64£11.22M£1.65171.82

44.0% of Creo Medical Group shares are owned by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. 7.6% of Creo Medical Group shares are owned by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Creo Medical Group had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for Creo Medical Group and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.80 beat Creo Medical Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Creo Medical Group Neutral
Advanced Medical Solutions Group Positive

Advanced Medical Solutions Group has a net margin of 1.58% compared to Creo Medical Group's net margin of -268.57%. Advanced Medical Solutions Group's return on equity of 1.44% beat Creo Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Creo Medical Group-268.57% -38.29% -20.09%
Advanced Medical Solutions Group 1.58%1.44%2.35%

Creo Medical Group has a beta of 1.563854, indicating that its share price is 56% more volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.759, indicating that its share price is 24% less volatile than the broader market.

Summary

Advanced Medical Solutions Group beats Creo Medical Group on 10 of the 16 factors compared between the two stocks.

Get Advanced Medical Solutions Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

MetricAdvanced Medical Solutions GroupHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£616.37M£5.99B£7.86B£2.84B
Dividend Yield1.01%1.69%2.47%5.11%
P/E Ratio171.5239.1434.4123.37
Price / Sales2.644.908.095.05
Price / Cash7.8724.1821.0220.23
Price / Book2.504.964.782.51
Net Income£11.22M£143.12M£3.52B£5.88B
7 Day PerformanceN/A-4.60%-4.98%-0.01%
1 Month Performance0.35%-2.38%-3.20%-2.14%
1 Year Performance33.18%-0.13%-0.27%7.21%

Advanced Medical Solutions Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMS
Advanced Medical Solutions Group
0.2996 of 5 stars
GBX 283
flat
GBX 278.33
-1.6%
+33.4%£616.37M£233.63M171.5210
NIOX
NIOX Group
2.2517 of 5 stars
GBX 64
+0.6%
GBX 86
+34.4%
-6.6%£259.35M£47.50M39.2692
TSTL
Tristel
N/AGBX 394
+0.6%
N/A+3.9%£189.41M£51.12M23.78208
EKF
EKF Diagnostics
N/AGBX 24.40
-0.4%
GBX 35
+43.4%
-7.0%£104.42M£51.35M42.07356
SPEC
INSPECS Group
N/AGBX 85
flat
N/A+19.9%£92.80M£193.23MN/A1,673

Related Companies and Tools


This page (LON:AMS) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners